PFIZER INC — Director's Dealing 2020

Oct 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerevel Therapeutics Holdings, Inc. (CERF)
CIK: 0001805387
Period of Report: 2020-10-27

Reporting Person: PFIZER INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-27	Common Stock	P	1200000	$10	Acquired	27349211	Direct

Footnotes

F1: On October 27, 2020, Pfizer Inc. purchased 1,200,000 shares of the Common Stock of Cerevel Therapeutics Holdings, Inc. (f/k/a ARYA Sciences Acquisition Corp II, the "Issuer") from the Issuer at a price of $10.00 per share in a private investment in public equity (PIPE) financing.